Epitope-blocking enzyme-linked immunosorbent assay to differentiate West Nile virus from Japanese encephalitis virus infections in equine sera

Clinical and Vaccine Immunology

Volumn 14, Issue 8, 2007, Pages 1024-1031

  Kitai, Yoko ^a   Shoda, Mizue ^a   Kondo, Takashi ^b   Konishi, Eiji ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EQUINE RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; NONSTRUCTURAL PROTEIN 1; VIRUS ANTIBODY; VIRUS ANTIGEN; DIAGNOSTIC AGENT; JAPANESE ENCEPHALITIS VACCINE; NS1 PROTEIN, FLAVIVIRUS; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ARTICLE; CHO CELL; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC ENCEPHALITIS; HORSE; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS DETECTION; WEST NILE FLAVIVIRUS; ANIMAL; ANIMAL DISEASE; ANTIBODY SPECIFICITY; BLOOD; CERCOPITHECUS; CLASSIFICATION; EVALUATION; HORSE DISEASE; IMMUNOLOGY; METHODOLOGY; VERO CELL; VIROLOGY; VIRUS INFECTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CERCOPITHECUS AETHIOPS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HORSE DISEASES; HORSES; JAPANESE ENCEPHALITIS VACCINES; VERO CELLS; VIRAL NONSTRUCTURAL PROTEINS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 35248825146     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00051-07     Document Type: Article

References (53)

1. Blitvich, B. J., I. Fernandez-Salas, J. F. Contreras-Cordero, N. L. Marlenee, J. I. Gonzalez-Rojas, N. Komar, D. J. Gubler, C. H. Calisher, and B. J. Beaty. 2003. Serologic evidence of West Nile virus infection in horses, Coahuila State, Mexico. Emerg. Infect. Dis. 9:853-856.
2. Blitvich, B. J., N. L. Marlenee, R. A. Hall, C. H. Calisher, R. A. Bowen, J. T. Roehrig, N. Komar, S. A. Langevin, and B. J. Beaty. 2003. Epitope-blocking enzyme-linked immunosorbent assays for the detection of serum antibodies to West Nile virus in multiple avian species. J. Clin. Microbiol. 41:1041-1047.
3. Blitvich, B. J., D. Scanlon, B. J. Shiell, J. S. Mackenzie, and R. A. Hall. 1999. Identification and analysis of truncated and elongated species of the flavivirus NS1 protein. Virus Res. 60:67-79.
4. Burke, D. S., and T. P. Monath. 2001. Flavivirus, p. 1043-1125. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
5. Calisher, C. H., and E. A. Gould. 2003. Taxonomy of the virus family Flaviviridae. Adv. Virus Res. 59:1-19.
6. Castillo-Olivares, J., and J. Wood. 2004. West Nile virus infection of horses. Vet. Res. 35:467-483.
7. Dauphin, G., and S. Zientara. 18 January 2007, posting date. West Nile virus: recent trends in diagnosis and vaccine development. Vaccine. doi:10.1016/j.vaccine.2006.12.005.
8. Hall, R. A., A. K. Broom, A. C. Hartnett, M. J. Howard, and J. S. Mackenzie. 1995. Immunodominant epitopes on the NS1 protein of MVE and KUN viruses serve as targets for a blocking ELISA to detect virus-specific antibodies in sentinel animal serum. J. Virol. Methods 51:201-210.
9. Hall, R. A., B. H. Kay, G. W. Burgess, P. Clancy, and I. D. Fanning. 1990. Epitope analysis of the envelope and non-structural glycoproteins of Murray Valley encephalitis virus. J. Gen. Virol. 71:2923-2930.
10. Hall, R. A., J. H. Scherret, and J. S. Mackenzie. 2001. Kunjin virus: an Australian variant of West Nile? Ann. N. Y. Acad. Sci. 951:153-160.
11. Hanna, J. N., S. A. Ritchie, D. A. Phillips, J. Shield, M. C. Bailey, J. S. Mackenzie, M. Poidinger, B. J. McCall, and P. J. Mills. 1996. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med. J. Aust. 165:256-260.
12. Hayes, E. B., and D. J. Gubler. 2006. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu. Rev. Med. 57:181-194.
13. Henchal, E. A., M. K. Gentry, J. M. McCown, and W. E. Brandt. 1982. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am. J. Trop. Med. Hyg. 31:830-836.
14. Ishikawa, T., and E. Konishi. 2006. Mosquito cells infected with Japanese encephalitis virus release slowly-sedimenting hemagglutinin particles in association with intracellular formation of smooth membrane structures. Microbiol. Immunol. 50:211-223.
15. Kobayashi, M., and I. Kurane. 2003. Guidelines for the countermeasure to vector mosquitoes of West Nile Fever. National Institute of Infectious Diseases, Tokyo, Japan. (In Japanese.)
16. Komar, N. 2003. West Nile virus: epidemiology and ecology in North America. Adv. Virus. Res. 61:185-234.
17. Komar, O., M. B. Robbins, K. Klenk, B. J. Blitvich, N. L. Marlenee, K. L. Burkhalter, D. J. Gubler, G. Gonzálvez, C. J. Peña, A. T. Peterson, and N. Komar. 2003. West Nile virus transmission in resident birds, Dominican Republic. Emerg. Infect. Dis. 9:1299-1302.
18. Konishi, E. 1997. Monoclonal antibodies multireactive with parasite antigens produced by hybridomas generated from naive mice. Parasitology 115:387-393.
19. Konishi, E., and A. Fujii. 2002. Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine. Vaccine 20:1058-1067.
20. Konishi, E., A. Fujii, and P. W. Mason. 2001. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. J. Virol. 75:2204-2212.
21. Konishi, E., S. Kosugi, and J. Imoto. 2006. Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice. Vaccine 24:2200-2207.
22. Konishi, E., M. Shoda, N. Ajiro, and T. Kondo. 2004. Development and evaluation of an enzyme-linked immunosorbent assay for quantifying antibodies to Japanese encephalitis virus nonstructural 1 protein to detect subclinical infections in vaccinated horses. J. Clin. Microbiol. 42:5087-5093.
23. Konishi, E., M. Shoda, and T. Kondo. 2004. Prevalence of antibody to Japanese encephalitis virus nonstructural 1 protein among racehorses in Japan: indication of natural infection and need for continuous vaccination. Vaccine 22:1097-1103.
24. Konishi, E., M. Shoda, and T. Kondo. 2006. Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist. Vaccine 24:516-524.
25. Konishi, E., and T. Suzuki. 2002. Ratios of subclinical to clinical Japanese encephalitis (JE) virus infections in vaccinated populations: evaluation of an inactivated JE vaccine by comparing the ratios with those in unvaccinated populations. Vaccine 22:98-107.
26. Koraka, P., H. Zeller, M. Niedrig, A. D. Osterhaus, and J. Groen. 2002. Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect. 4:1209-1215.
27. Kozak, M. 1986. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283-292.
28. Kuno, G. 2003. Serodiagnosis of flaviviral infections and vaccinations in humans. Adv. Virus Res. 61:3-65.
29. Kurane, I. 2005. West Nile fever, p. 104-105. In Japan Medical Association and Ministry of Health, Labour and Welfare (ed.). Guidelines for diagnosis and treatments of infectious diseases 2004. Igakushoin, Tokyo, Japan. (In Japanese.)
30. Lai, C. J., and T. P. Monath. 2003. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis. Adv. Virus Res. 61:469-509.
31. Lian, W. C., M. Y. Liau, and C. L. Mao. 2002. Diagnosis and genetic analysis of Japanese encephalitis virus infected in horses. J. Vet. Med. B Infect. Dis. Vet. Public Health 49:361-365.
32. Lin, Y. L., L. K. Chen, C. L. Liao, C. T. Yeh, S. H. Ma, J. L. Chen, Y. L. Huang, S. S. Chen, and H. Y. Chiang. 1998. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J. Virol. 72:191-200.
33. Lindenbach, B. D., and C. M. Rice. 2001. Flaviviridae: the viruses and their replication, p. 991-1041. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
34. Lvov, D. K., A. M. Butenko, V. L. Gromashevsky, V. P. Larichev, S. Y. Gaidamovich, O. I. Vyshemirsky, A. N. Zhukov, V. V. Lazorenko, V. N. Salko, A. I. Kovtunov, K. M. Galimzyanov, A. E. Platonov, T. N. Morozova, N. V. Khutoretskaya, E. O. Shishkina, and T. M. Skvortsova. 2000. Isolation of two strains of West Nile virus during an outbreak in southern Russia, 1999. Emerg. Infect. Dis. 6:373-376.
35. Mackenzie, J. S., D. J. Gubler, and L. R. Petersen. 2004. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10(Suppl.):S98-S109.
36. McLean, R. G., S. R. Ubico, D. Bourne, and N. Komar. 2002. West Nile virus in livestock and wildlife. Curr. Top. Microbiol. Immunol. 267:271-308.
37. Ministry of Agriculture, Forestry and Fisheries and Ministry of Health, Labour and Welfares, Japan. 2003. Manuals for prevention from West Nile virus infections. Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan. (In Japanese.)
38. Minton, C. 2004. What have we learned from banding and flagging waders in Australia? p. 116-142. In P. Straw (ed.), Status and conservation of shorebirds in the East Asian-Australasian flyway. Australasian Wader Studies Group and Wetlands International - Oceania, Sydney, Australia.
39. Morales, M. A., M. Barrandeguy, C. Fabbri, J. B. Garcia, A. Vissani, K. Trono, G. Gutierrez, S. Pigretti, H. Menchaca, N. Garrido, N. Taylor, F. Fernandez, S. Levis, and D. Enría. 2006. West Nile virus isolation from equines in Argentina, 2006. Emerg. Infect. Dis. 12:1559-1561.
40. Petersen, L. R., and A. A. Marfin. 2005. Shifting epidemiology of Flaviviridae. J. Travel. Med. 12(Suppl.):S3-S11.
41. Platonov, A. E. 2001. West Nile encephalitis in Russia 1999-2001. Were we ready? Are we ready? Ann. N. Y. Acad. Sci. 951:102-116.
42. ProMED-mail. 24 January 2005. Confirmation of circulation of West Nile virus in birds in the Far Eastern region of Russia. Archive no. 20050124.0260. http://www.promedmail.org.
43. ProMED-mail. 30 June 2004. West Nile virus in birds in the Vladivostok Region. Archive no. 20040630.1744. http://www.promedmail.org.
44. Putnak, R., K. Porter, and C. Schmaljohn. 2003. DNA vaccines for flaviviruses. Adv. Virus Res. 61:445-468.
45. Reed, K. D., J. K. Meece, J. S. Henkel, and S. K. Shukla. 2003. Birds, migration and emerging zoonoses: West Nile virus, Lyme disease, influenza A and enteropathogens. Clin. Med. Res. 1:5-12.
46. Sejvar, J. J., and A. A. Marfin. 2006. Manifestations of West Nile neuroinvasive disease. Rev. Med. Virol. 16:209-224.
47. Shi, P. Y., and S. J. Wong. 2003. Serologic diagnosis of West Nile virus infection. Expert Rev. Mol. Diagn. 3:733-741.
48. Solomon, T., and D. W. Vaughn. 2002. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr. Top. Microbiol. Immunol. 267:171-194.
49. Turell, M. J., M. R. Sardelis, M. L. O'Guinn, and D. J. Dohm. 2002. Potential vectors of West Nile virus in North America. Curr. Top. Microbiol. Immunol. 267:241-252.
50. Usuku, S., Y. Noguchi, and T. Takasaki. 2004. Newly developed TaqMan assay to detect West Nile viruses in a wide range of viral strains. Jpn. J. Infect. Dis. 57:129-130.
51. Williams, D. T., P. W. Daniels, R. A. Lunt, L. F. Wang, K. M. Newberry, and J. S. Mackenzie. 2001. Experimental infections of pigs with Japanese encephalitis virus and closely related Australian flaviviruses. Am. J. Trop. Med. Hyg. 65:379-387.
52. Wong, S. J., R. H. Boyle, V. L. Demarest, A. N. Woodmansee, L. D. Kramer, H. Li, M. Drebot, R. A. Koski, E. Fikrig, D. A. Martin, and P. Y. Shi. 2003. Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J. Clin. Microbiol. 41:4217-4223.
53. Wu, S. J., G. Grouard-Vogel, W. Sun, J. R. Mascola, E. Brachtel, R. Putvatana, M. K. Louder, L. Filgueira, M. A. Marovich, H. K. Wong, A. Blauvelt, G. S. Murphy, M. L. Robb, B. L. Innes, D. L. Birx, C. G. Hayes, and S. S. Frankel. 2000. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6:816-820.